Current strategies for vaccination in glioblastoma

Dutoit Vallotton, Valérie; Migliorini, Denis; Dietrich, Pierre-Yves

doi:10.1097/CCO.0000000000000575

Scientific article

Review

English

Current strategies for vaccination in glioblastoma

ContributorsDutoit Vallotton, Valérie

; Migliorini, Denis; Dietrich, Pierre-Yves

Published inCurrent Opinion in Oncology, vol. 31, no. 6, p. 514-521

Publication date2019

Abstract

Immunotherapy is viewed as a promising approach for glioblastoma and, in particular, therapeutic vaccines are being intensively studied. Here, we review results provided by recent clinical trials of glioblastoma vaccination and discuss the required strategies to optimize such approaches.

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Immunothérapie des cancers (42)

Funding

Autre - Fondation Lionel Perrier, Association Frederic Fellay, Fondation Privée des Hôpitaux Universitaires de Genève, Fond'action and Association Marietta

Citation (ISO format)

DUTOIT VALLOTTON, Valérie, MIGLIORINI, Denis, DIETRICH, Pierre-Yves. Current strategies for vaccination in glioblastoma. In: Current Opinion in Oncology, 2019, vol. 31, n° 6, p. 514–521. doi: 10.1097/CCO.0000000000000575

Article (Published version)

Identifiers

PID : unige:124206
DOI : 10.1097/CCO.0000000000000575
PMID : 31403483

Journal ISSN1040-8746

355views

5downloads

Creation03/09/2019 17:20:00

First validation03/09/2019 17:20:00

Update time15/03/2023 18:08:13

Status update15/03/2023 18:08:13

Last indexation31/10/2024 16:28:40

Archive ouverte UNIGE

Current strategies for vaccination in glioblastoma

Immunotherapy is viewed as a promising approach for glioblastoma and, in particular, therapeutic vaccines are being intensively studied. Here, we review results provided by recent clinical trials of glioblastoma vaccination and discuss the required strategies to optimize such approaches.

Technical informations